Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
We are giddy at .40 to .42
good grief... but hey better than .35
HOW ABOUT INSIDER BUYING PPPHM
WOuld do more than the press release and confirm your belief in the future of the company.
Come on MANAGEMENT AND BOARD MEMBERS!!!
TO PPHM Managagement: Please BUY HERE!
ALSO BOARD MEMBERS. Need some insider support here!!!!
Yea volgoat.. remember when they
siad it was dead, then months later put out the PR saying in talks with DTRA. Never ever know what is going to happen with the GOVT, shoulda just kept their mouths shut. Certainly did not help our SP knowing they were looking at PPHM. So a surprise would have been nice but now we get the other side. Expectation not met. Then again people would have found out and accused them of hiding something.
Why were they in for a 3rd audit if did not have money unless were trying to find money elsewhere and did not work out??
PPHMLOVER... if they
did not have a CC you would be bitching about they are not updating you, keeping secrets etc.
Sometimes things just do not go as fast as you say, think, or want them to.
GO VOLS!!!!
Whooping some ARK ass... right now.
WHY does Cinn
want to keep a lid on it?
1.4 million shares.. PPS Up
Can't find any news? What up? High of .65.
RB post... Tamiflu
PARIS (AFP) — Swedish scientists say that Tamiflu -- the frontline weapon in any bird-flu pandemic -- cannot be broken down by sewage systems and this could help the virus mutate dangerously into a drug-resistant strain.
Countries around the world are stockpiling Tamiflu in the belief it will help curb any future outbreak of H5N1 avian flu among humans.
Tamiflu, whose lab name is oseltamivir, is not a cure for flu but can ease its symptoms, thus aiding vulnerable patients such as the elderly, and reduce the time of illness, thus easing the burden on caregivers.
Scientists led by Jerker Fick, a chemist at Umea University, tested the survivability of the Tamiflu molecule in water drawn from three phases in a typical sewage system.
The first was raw sewage water; the second was water that had been filtered and treated with chemicals; the third was water from "activated sludge," in which microbes are used to digest waste material.
Tamiflu's active ingredient survived all three processes, which means that it is released in the waste water leaving the plant.
The finding is important because of the risk that Tamiflu, if overprescribed, could end up in the wild in concentrations high enough to let H5N1 adapt to this key drug, the authors say.
Flu viruses are common among waterfowl, especially dabbling ducks such as mallards which often forage for food near sewage outlets.
"The biggest threat is that resistance will become common among low pathogenic influenza viruses carried by wild ducks," said co-author Bjoern Olsen, professor of infectious diseases at the University of Uppsala and University of Kalmar.
These avian viruses could then recombinate with ordinary human flu viruses, creating new strains that are resistant to Tamiflu, he said.
"Antiviral medicines such as Tamiflu must be used with care and only when the medical situation justifies it," Olsen warned. "Otherwise, there is a risk that they will be ineffective when most needed, such as during the next influenza pandemic."
The study, published online on Wednesday by the open-access Public Library of Science (PLoS), pointed the finger at Japan.
It quoted figures from Swiss maker Roche, which estimated that in the 2004-5 influenza season, 16 million Japanese fell ill with flu, of whom six million received Tamiflu.
At such dosages, the amount of Tamiflu released into the Japanese environment is roughly equivalent to what is predicted in areas where the drug would be widely used in a pandemic.
Coincidentally, "Japan also has a high rate of emerging resistance to Tamiflu," the paper said. A 2004 study published in The Lancet found that among a small group of infected Japanese children, 18 percent had a mutated form of the virus that made these patients between 300 and 100,000 times more resistant to Tamiflu.
Hosted by Google
Copyright © 2007 AFP. All rights reserved.
Pergrine may be on to something...
http://seekingalpha.com/article/47860-peregrine-pharmaceuticals-may-be-on-to-something
SO TYP...
"They've had their chances...time for a change."
Don't get me wrong I am long big and down big but who exactly is the new management that you see that will take over the company?
OOPs...
Sure they do in places you do not know about and "others" that THEY control.
TYP...
"I know one thing for sure, management and the BOD don't own enough shares to beat our proposals."
Sure they do in places you do not know about and "others" that the control.
Another Article...
http://www.cancerpage.com/news/article.asp?id=11329
Oops...noticed THAT TYP
Do not want any typos. Pay for those with derision.
Noticed the TYP...
MSCatie is an expert now. WOW.
More insider buying...
16,485 shares by David King at $.59+
Steve Butabi....
Keep on posting and promoting PPHM to the right people. Interesting. Would not bother me in the least to have some high profile big boys buy in and help current management!!!
Notuncoolish....
Know of any more coming?
Insider buying...
Everybody happy now. I am sure it is not enough shares though, right.
A reason to live...
that I like. Billy comin after ya!!!
Not wating on the WIFE...
doing myself in tonight to beat her to the punch.
BIG ON...
Think I will come out of PPHM investment alive? How long do you estimate that I will live in FEAR?
Lou... BOT BOT BOT
I think alot of us in the same boat.
Should we continue to believe?
God help us all....
BIG ON...
I hope you are RIGHT.
I am have to sleep with one eye open to keep watch out for my wife coming at me with a sharp object.
Please be right BOT... for my sake!!!
Steve...
Why did Barclays hold on to 2.48 million shares since now out of Russell? Why weren't all shares sold?
"You do realize that the ONLY reason Barclays ever owned PPHM is because it was part of the russell, right? Barclays doen't even know nor care what PPHM does. They run INDEX funds that buy all stocks in a certain index. When stocks are removed from that index they SELL. That is what you saw with Barclays. Please, some of you really scare me sometimes! Did you really not know that?"
Good post KT and JJPK...
Getting tired of all the whining.
will get 360 total days... automatic. Nasdaq likes money.
Peregrine will be automatically afforded an initial 180 calendar days, or until January 22, 2008, to regain compliance with this requirement. To regain compliance, the closing bid price of Peregrine's common stock must meet or exceed $1.00 per share for 10 consecutive business days.
This notification has no effect on the Nasdaq listing or trading of the company's common stock.
According to Nasdaq market regulations, companies are eligible for an additional 180-day period to regain compliance provided that on the 180th day of the first compliance period, the company demonstrates that it meets the criteria for initial listing set forth in Rule 4310(c), except for the minimum bid price requirement.
Peregrine currently meets all other listing requirements set forth in Rule 4310(c).
Have 360 days...
to get back over a buck for 10 days. Can we do it?
oops THEIR money...
You get great data...
gonna be hard to hide. We are not living in 1850 or 1950. Data does not hide well these days if it is for real people will find out.
If treatment starts in another country US citizens will find out there is a treatment and fly there to spend there money.
What would you do if you were terminal?
Flying...
Another $44.5 million dollars of non-dilutive money in the bank would be nice too.
We shall see....
Didn't a few other people say the same thing as your friend? Isn't that what PPHM said in the CC in a round about way?
Better to take dilution now for a better deal in PHII especially after seeing the data we have seen so far?
6 months is a long time...
do not think letter will do anything.
Below $1.00 for 6 months...
to get delisted.
CJDIDDY....
Your transcript will beat my notes, look forward to reading it. Hard to type and listen 100% at same time.
GOOD LUCK TO US ALL!!!!! I need PPS to go up b4 wife slices off cajones.
Notes...
as fast as I could type and listen.... excuse spelling etc.
Did financing because felt it was better than what a "partner" (BP) would offer at this time. Phase II data historically dirves value, make better deals with this data. Soon have 6 PII trials.
$32MM on hand, most in history. Drive trials.
6 PhII planned
PH1B trial, 4th relapse, enrollment went well, 50% objective tumor response, 75% gemcibine OBT. Greater than 30% tumor shrinkage, safety same as just with chemo.
US trial, clinical data from India and US studies and preclinical, support moving Bavi into PHII. Implement 6PHII trials. First announced today.
India protocol submitted, 21 patients safety and efficacy, 2nd stage add 28.... total 49 patients.
Must be approved by India, hopefully initiate by fall.
Want to evaluate different cancers with diff. chemos, like DNA.
File protocols for 5 more with diff tumor types, chemo and radiation.
Interest in BP, but PHII data is where you drive value
Cotara PHII beginning soon, treat 40 patients, safety efficacy, clinical sites already identifying patients, start soon
MUSC Cotara, Dr. Patel already run pre clinical. Working with Media out reach.
Strong interest from partners on Cotara, positive data create value
HCV, 24 patients, 4 doses as solo, good safety and promising data, Duke looking at.
Bavi binding to HCV and HIV, support HIV/HCV trial. Pleased to announce trial. Dose escalation trial of 24 patients. Safety and viral load reduction. Weekly dosing for 8 weeks, longer treatment. Dr. Smith active involvement a plus.
Collab with Duke is strong, new insights on HIV. Look forward to reporting results.
Trial to get optimal Bavi dose for HCV. Data from HCV/HIV give data.
Test with HCV drugs.
We and advisors are very pleased with results to date
Summary.... look forward to FY 2008 (in FY 2008 now). Robust pipeline, 11 trials in FY 2008.
Cotara PHII trial
Expand clinical, IB on board to help, road shows, news flow broader media outreach. PHII better media coverage, improved PPS.
Q&A
Brandon Cox-Private Investor
Cotara... MRI every 2 months? Will it blow away Standard of Care. Fast Track status?
Excited, periodic MRIs. Median survival time. Median time to progression. Progress trial quickly, update when possible. Fast Track, if can get numbers like b4 may get fast track.
HOW SICK ARE PATIENTS IN LUNG CANCER?
PH1b study still on treatment, but do not get data.
Patient pop will be healthier than PHI, no data, will vary by patient
Robert Browell - PI
Joint Venture, No PIPEs, why no BP partner.
A: Raise money ourselves and be aggressive, Dilution with partner would have been more without PHII. Pleased with trials to date. Felt from data right move to do PIPE. No bonuses.
Merrill Lynch
Congrats on such a small co. starting 6 PHII trials.
Small cell lung why?
Natural with chemo, easier to get patients, encouraged by PH1 study.
Will see variety of diff types of cancer and chemos in other 5 trials
6 chemo doses and 8 bavi. Chemo every 3rd week, get bavi every week. 18 weeks, or until they progress (until cancer gets worse). Grow by more 30% or new lesions off trial. Monitor at 8 weeks to see if drug effects, 8 wks general test time
Saks Investment research
Avid, capacity, more deals to gen. cash.
A: Additional capacity, Avid drive Bavi. Believe uptick in Avid, revs excess of reported FY07.
Summary
Believe stongest position ever, financial, look forward to creating value.
News and we go...
down. Geez. Hope results are GOOD!
DNA... PPHM?
So if hold PPHM next 18 years I could be worth $100,000,000.
WOO HOO as Homer Simpson would say.
I would take 1% of that and be happy.